Clin Endosc.  2021 Jan;54(1):17-24. 10.5946/ce.2021.019.

The Efficacy and Safety of Endoscopic Sleeve Gastroplasty as an Alternative to Laparoscopic Sleeve Gastrectomy

• Yoon JY
• Arau RT
• The study group for endoscopic bariatric and metabolic therapies in the Korean Society of Gastrointestinal Endoscopy

• KMID: 2512305
• DOI: http://doi.org/10.5946/ce.2021.019

Abstract

Endoscopic sleeve gastroplasty (ESG) is a therapeutic endoscopic technique for reducing the size of the gastric reservoir in obese patients, using a full-thickness endoscopic suturing device. The effectiveness of ESG in weight loss is significantly greater than that of high-intensity diet and lifestyle therapy and lower than that of laparoscopic sleeve gastrectomy (LSG). The efficacy at 12 months after ESG in terms of percentage of total body weight loss and excess body weight loss was approximately 16% and 60%, respectively. The well-known predictive factors for increased weight loss by ESG are good compliance with regular monitoring and post-procedure care involving a multidisciplinary team approach. Although the underlying mechanism of weight loss induced by ESG is debatable, delayed gastric emptying and early satiation are some of the proposed mechanisms. The pooled rate of adverse events after ESG reported in several meta-analysis studies ranged from 1.5% to 2.3% and the incidence of new-onset gastroesophageal reflux disease after ESG was negligible, indicating that ESG has a superior safety profile to LSG. Moreover, ESG reduced the risk of obesity-related metabolic comorbidities, evidenced by the reduction in HbA1c level, systolic blood pressure, triglyceride level, and risk of hepatic steatosis and fibrosis; it even improved the quality of life. ESG could be considered safe and qualify as an alternative treatment to LSG.

Keyword

Efficacy; Endoscopic sleeve gastroplasty; Laparoscopic sleeve gastroplasty; Obesity; Safety

Figure

• 

  Fig. 1. (A) Laparoscopic sleeve gastrectomy. (B) Endoscopic sleeve gastroplasty (used with permission of Mayo Foundation for Medical Education and Research, all rights reserved).

• 

  Fig. 2. Endoscopic sleeve gastroplasty performed using a full-thickness endoscopic suturing device (used with permission of Mayo Foundation for Medical Education and Research, all rights reserved)

Reference

1. Rønningen R, Wammer ACP, Grabner NH, Valderhaug TG. Associations between lifetime adversity and obesity treatment in patients with morbid obesity. Obes Facts. 2019; 12:1–13.

2. Gloy VL, Briel M, Bhatt DL, et al. Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials. BMJ. 2013; 347:f5934.

3. Ali M, El Chaar M, Ghiassi S, Rogers AM. American Society for Metabolic and Bariatric Surgery updated position statement on sleeve gastrectomy as a bariatric procedure. Surg Obes Relat Dis. 2017; 13:1652–1657.

4. Chang SH, Stoll CR, Song J, Varela JE, Eagon CJ, Colditz GA. The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003-2012. JAMA Surg. 2014; 149:275–287.

5. ASGE Bariatric Endoscopy Task Force; ASGE Technology Committee, Abu Dayyeh BK, et al. Endoscopic bariatric therapies. Gastrointest Endosc. 2015; 81:1073–1086.

6. Neylan CJ, Dempsey DT, Tewksbury CM, Williams NN, Dumon KR. Endoscopic treatments of obesity: a comprehensive review. Surg Obes Relat Dis. 2016; 12:1108–1115.

7. Abu Dayyeh BK, Rajan E, Gostout CJ. Endoscopic sleeve gastroplasty: a potential endoscopic alternative to surgical sleeve gastrectomy for treatment of obesity. Gastrointest Endosc. 2013; 78:530–535.

8. Lopez-Nava G, Galvão MP, Bautista-Castaño I, Jimenez-Baños A, Fernandez-Corbelle JP. Endoscopic sleeve gastroplasty: how I do it? Obes Surg. 2015; 25:1534–1538.

9. Cheskin LJ, Hill C, Adam A, et al. Endoscopic sleeve gastroplasty versus high-intensity diet and lifestyle therapy: a case-matched study. Gastrointest Endosc. 2020; 91:342–349.e1.

10. Hedjoudje A, Abu Dayyeh BK, Cheskin LJ, et al. Efficacy and safety of endoscopic sleeve gastroplasty: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020; 18:1043–1053.e4.

11. de Miranda Neto AA, de Moura DTH, Ribeiro IB, et al. Efficacy and safety of endoscopic sleeve gastroplasty at mid term in the management of overweight and obese patients: a systematic review and meta-analysis. Obes Surg. 2020; 30:1971–1987.

12. Due-Petersson R, Poulsen IM, Hedbäck N, Karstensen JG. Effect and safety of endoscopic sleeve gastroplasty for treating obesity - a systematic review. Dan Med J. 2020; 67:A05200359.

13. Li P, Ma B, Gong S, Zhang X, Li W. Efficacy and safety of endoscopic sleeve gastroplasty for obesity patients: a meta-analysis. Surg Endosc. 2020; 34:1253–1260.

14. Singh S, Hourneaux de Moura DT, Khan A, Bilal M, Ryan MB, Thompson CC. Safety and efficacy of endoscopic sleeve gastroplasty worldwide for treatment of obesity: a systematic review and meta-analysis. Surg Obes Relat Dis. 2020; 16:340–351.

15. Neto MG, Moon RC, de Quadros LG, et al. Safety and short-term effectiveness of endoscopic sleeve gastroplasty using overstitch: preliminary report from a multicenter study. Surg Endosc. 2020; 34:4388–4394.

16. Sharaiha RZ, Hajifathalian K, Kumar R, et al. Five-year outcomes of endoscopic sleeve gastroplasty for the treatment of obesity. Clin Gastroenterol Hepatol. 2020; Oct. 1. [Epub]. https://doi.org/10.1016/j.cgh.2020.09.055.

17. Novikov AA, Afaneh C, Saumoy M, et al. Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic band for weight loss: how do they compare? J Gastrointest Surg. 2018; 22:267–273.

18. Fayad L, Adam A, Schweitzer M, et al. Endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: a case-matched study. Gastrointest Endosc. 2019; 89:782–788.

19. Lopez-Nava G, Asokkumar R, Bautista-Castaño I, et al. Endoscopic sleeve gastroplasty, laparoscopic sleeve gastrectomy, and laparoscopic greater curve plication: do they differ at 2 years? Endoscopy. 2020; Jul. 22. [Epub]. https://doi.org/10.1055/a-1224-7231.

20. Jalal MA, Cheng Q, Edye MB. Systematic review and meta-analysis of endoscopic sleeve gastroplasty with comparison to laparoscopic sleeve gastrectomy. Obes Surg. 2020; 30:2754–2762.

21. Mohan BP, Asokkumar R, Khan SR, et al. Outcomes of endoscopic sleeve gastroplasty; how does it compare to laparoscopic sleeve gastrectomy? A systematic review and meta-analysis. Endosc Int Open. 2020; 8:E558–E565.

22. Singh S, de Moura DTH, Khan A, et al. Intragastric balloon versus endoscopic sleeve gastroplasty for the treatment of obesity: a systematic review and meta-analysis. Obes Surg. 2020; 30:3010–3029.

23. Espinet-Coll E, Nebreda-Durán J, Galvao-Neto M, et al. Suture pattern does not influence outcomes of endoscopic sleeve gastroplasty in obese patients. Endosc Int Open. 2020; 8:E1349–E1358.

24. Sharaiha RZ, Kumta NA, Saumoy M, et al. Endoscopic sleeve gastroplasty significantly reduces body mass index and metabolic complications in obese patients. Clin Gastroenterol Hepatol. 2017; 15:504–510.

25. Bhandari M, Jain S, Mathur W, et al. Endoscopic sleeve gastroplasty is an effective and safe minimally invasive approach for treatment of obesity: first Indian experience. Dig Endosc. 2020; 32:541–546.

26. Barrichello S, Hourneaux de Moura DT, Hourneaux de Moura EG, et al. Endoscopic sleeve gastroplasty in the management of overweight and obesity: an international multicenter study. Gastrointest Endosc. 2019; 90:770–780.

27. Saumoy M, Schneider Y, Zhou XK, et al. A single-operator learning curve analysis for the endoscopic sleeve gastroplasty. Gastrointest Endosc. 2018; 87:442–447.

28. Prevot F, Verhaeghe P, Pequignot A, et al. Two lessons from a 5-year follow-up study of laparoscopic sleeve gastrectomy: persistent, relevant weight loss and a short surgical learning curve. Surgery. 2014; 155:292–299.

29. Hill C, El Zein M, Agnihotri A, et al. Endoscopic sleeve gastroplasty: the learning curve. Endosc Int Open. 2017; 5:E900–E904.

30. Lopez-Nava G, Asokkumar R, Rull A, Corbelle F, Beltran L, Bautista I. Bariatric endoscopy procedure type or follow-up: what predicted success at 1 year in 962 obese patients? Endosc Int Open. 2019; 7:E1691–E1698.

31. Lopez-Nava G, Galvao M, Bautista-Castaño I, Fernandez-Corbelle JP, Trell M. Endoscopic sleeve gastroplasty with 1-year follow-up: factors predictive of success. Endosc Int Open. 2016; 4:E222–E227.

32. Abu Dayyeh BK, Acosta A, Camilleri M, et al. Endoscopic sleeve gastroplasty alters gastric physiology and induces loss of body weight in obese individuals. Clin Gastroenterol Hepatol. 2017; 15:37–43.e1.

33. Lopez-Nava G, Negi A, Bautista-Castaño I, Rubio MA, Asokkumar R. Gut and metabolic hormones changes after endoscopic sleeve gastroplasty (ESG) vs. laparoscopic sleeve gastrectomy (LSG). Obes Surg. 2020; 30:2642–2651.

34. Jirapinyo P, Thompson CC. Endoscopic bariatric and metabolic therapies: surgical analogues and mechanisms of action. Clin Gastroenterol Hepatol. 2017; 15:619–630.

35. Vargas EJ, Bazerbachi F, Calderon G, et al. Changes in time of gastric emptying after surgical and endoscopic bariatrics and weight loss: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2020; 18:57–68.e5.

36. Abu Dayyeh B, Rizk M, El-Mohsen MA, et al. Laparoscopic greater curvature plication (LGCP) vs. endoscopic sleeve gastroplasty (ESG): similar efficacy with different physiology. Surg Obes Relat Dis. 2017; 13(10 Suppl):S205.

37. de Moura DTH, Badurdeen DS, Ribeiro IB, Leite E, Thompson CC, Kumbhari V. Perspectives toward minimizing the adverse events of endoscopic sleeve gastroplasty. Gastrointest Endosc. 2020; 92:1115–1121.

38. Quero G, Fiorillo C, Dallemagne B, et al. The causes of gastroesophageal reflux after laparoscopic sleeve gastrectomy: quantitative assessment of the structure and function of the esophagogastric junction by magnetic resonance imaging and high-resolution manometry. Obes Surg. 2020; 30:2108–2117.

39. Oor JE, Roks DJ, Ünlü Ç, Hazebroek EJ. Laparoscopic sleeve gastrectomy and gastroesophageal reflux disease: a systematic review and meta-analysis. Am J Surg. 2016; 211:250–267.

40. Soricelli E, Casella G, Baglio G, Maselli R, Ernesti I, Genco A. Lack of correlation between gastroesophageal reflux disease symptoms and esophageal lesions after sleeve gastrectomy. Surg Obes Relat Dis. 2018; 14:751–756.

41. Asokkumar R, Babu MP, Bautista I, Lopez-Nava G. The use of the OverStitch for bariatric weight loss in Europe. Gastrointest Endosc Clin N Am. 2020; 30:129–145.

42. Inaba CS, Koh CY, Sujatha-Bhaskar S, Pejcinovska M, Nguyen NT. How safe is same-day discharge after laparoscopic sleeve gastrectomy? Surg Obes Relat Dis. 2018; 14:1448–1453.

43. Badurdeen D, Hoff AC, Hedjoudje A, et al. Endoscopic sleeve gastroplasty plus liraglutide versus endoscopic sleeve gastroplasty alone for weight loss. Gastrointest Endosc. 2020. Oct. 17. [Epub]. https://10.1016/j.gie.2020.10.016.

44. Nauck MA, Niedereichholz U, Ettler R, et al. Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans. Am J Physiol. 1997; 273:E981–E988.

45. Nuffer WA, Trujillo JM. Liraglutide: a new option for the treatment of obesity. Pharmacotherapy. 2015; 35:926–934.

46. de Moura EGH, et al. Endoscopic sleeve gastroplasty in the management of weight regain after sleeve gastrectomy. Endoscopy. 2020; 52:202–210.

47. Beitner M, Hopkins G. Conversion of endoscopic sleeve gastroplasty to laparoscopic Roux-en-Y gastric bypass. Surg Obes Relat Dis. 2020; 16:590–591.

48. Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015; 149:367–378.e5. –quiz e14-e15.

49. Alqahtani A, Al-Darwish A, Mahmoud AE, Alqahtani YA, Elahmedi M. Short-term outcomes of endoscopic sleeve gastroplasty in 1000 consecutive patients. Gastrointest Endosc. 2019; 89:1132–1138.

50. Mehta A, Hajifathalian K, Dawod QM, et al. An analysis of leptin and insulin-glucose metabolism following endoscopic sleeve gastroplasty. Gastroenterology. 2019; 156(6 Suppl 1):S–236.

51. Espinet Coll E, Vila Lolo C, Díaz Galán P, et al. Bariatric and metabolic endoscopy in the handling of fatty liver disease. A new emerging approach? Rev Esp Enferm Dig. 2019; 111:283–293.

52. Hajifathalian K, Mehta A, Ang B, et al. Improvement in insulin resistance and estimated hepatic steatosis and fibrosis after endoscopic sleeve gastroplasty. Gastrointest Endosc. 2020; Aug. 27. [Epub]. https://10.1016/j.gie.2020.08.023.

53. Fiorillo C, Quero G, Vix M, et al. 6-month gastrointestinal quality of life (QoL) results after endoscopic sleeve gastroplasty and laparoscopic sleeve gastrectomy: a propensity score analysis. Obes Surg. 2020; 30:1944–1951.

54. Lopez-Nava G, Asokkumar R, Lacruz T, Rull A, Beltran L, Bautista-Castaño I. The effect of weight loss and exercise on health-related quality of life (HRQOL) following endoscopic bariatric therapies (EBT) for obesity. Health Qual Life Outcomes. 2020; 18:130.

55. Abu Dayyeh BK, Kumar N, Edmundowicz SA, et al. ASGE Bariatric Endoscopy Task Force systematic review and meta-analysis assessing the ASGE PIVI thresholds for adopting endoscopic bariatric therapies. Gastrointest Endosc. 2015; 82:425–438.e5.